Changsheng is a well-known Chinese pharmaceutical company that specializes in the development, production, and distribution of vaccines and biopharmaceutical products.
Started as a state-owned enterprise in 1992
Expanded its product portfolio to include vaccines, bio-products, and blood products
Received numerous awards and recognition for its contributions to healthcare in China
Continues to invest in research and development to introduce innovative and effective medical solutions
A leading Chinese biopharmaceutical company specializing in vaccines, particularly for infectious diseases.
A biotechnology company focused on developing innovative vaccines for various diseases.
A global contract development and manufacturing organization that provides services for the biopharmaceutical industry.
Changsheng produces a range of vaccines to prevent infectious diseases, including influenza, hepatitis, and pertussis.
The company offers a variety of bio-products, such as immunoglobulins and monoclonal antibodies, for therapeutic use.
Changsheng manufactures blood products like albumin and intravenous immunoglobulin (IVIG) to meet medical needs.
Changsheng produces vaccines for infectious diseases like influenza, hepatitis, pertussis, among others.
Changsheng's main products include vaccines, bio-products, and blood products.
Sinovac Biotech, CanSino Biologics, and WuXi Biologics are some of Changsheng's competitors in the pharmaceutical industry.
Yes, Changsheng has received awards and recognition for its contributions to healthcare in China.
Yes, Changsheng continues to invest in research and development to introduce innovative medical solutions.